Ridgeline, a Versant Ventures Discovery Engine, was founded in early 2017 to create and operate Versant-financed innovative biotech companies in Basel, Switzerland. In its first year Ridgeline assembled an international team of 20 highly experienced drug discovery professionals and built and operated three new companies, including Black Diamond, Bright Peak and Monte Rosa.